光化激活9-羟基脱镁叶绿酸-α诱导人喉鳞状细胞癌HN-3细胞凋亡与迁徙抑制

何培杰, 毛雯静, 张焕康, 等. 光化激活9-羟基脱镁叶绿酸-α诱导人喉鳞状细胞癌HN-3细胞凋亡与迁徙抑制[J]. 临床耳鼻咽喉头颈外科杂志, 2015, 29(15): 1367-1371. doi: 10.13201/j.issn.1001-1781.2015.15.012
引用本文: 何培杰, 毛雯静, 张焕康, 等. 光化激活9-羟基脱镁叶绿酸-α诱导人喉鳞状细胞癌HN-3细胞凋亡与迁徙抑制[J]. 临床耳鼻咽喉头颈外科杂志, 2015, 29(15): 1367-1371. doi: 10.13201/j.issn.1001-1781.2015.15.012
HE Peijie, MAO Wenjing, ZHANG Huankang, et al. Apoptosis and migration suppression of HN-3human laryngeal squamous cancer cells induced by photo-activation of 9-hydroxypheophorbide-α[J]. J Clin Otorhinolaryngol Head Neck Surg, 2015, 29(15): 1367-1371. doi: 10.13201/j.issn.1001-1781.2015.15.012
Citation: HE Peijie, MAO Wenjing, ZHANG Huankang, et al. Apoptosis and migration suppression of HN-3human laryngeal squamous cancer cells induced by photo-activation of 9-hydroxypheophorbide-α[J]. J Clin Otorhinolaryngol Head Neck Surg, 2015, 29(15): 1367-1371. doi: 10.13201/j.issn.1001-1781.2015.15.012

光化激活9-羟基脱镁叶绿酸-α诱导人喉鳞状细胞癌HN-3细胞凋亡与迁徙抑制

详细信息
    通讯作者: 周梁,E-mail:zhoulent@126.com
  • 中图分类号: R739.62

Apoptosis and migration suppression of HN-3human laryngeal squamous cancer cells induced by photo-activation of 9-hydroxypheophorbide-α

More Information
  • 目的:探讨新型光敏剂9-羟基脱镁叶绿酸-α(9-HPbD)介导的光动力疗法(PDT)对HN-3人喉鳞状细胞癌细胞的凋亡诱导、迁徙抑制作用及其机制。方法:以不同浓度的9-HPbD(0.29 μg/ml, 0.59 μg/ml)孵育贴壁的HN-3细胞6 h,664 nm二极管激光(能量密度为2.0 J/cm2)照射光敏化的HN-3细胞15 min。光照后立即行细胞划痕,并于光照后0、12、24、36 h分别在相同划痕位置进行拍照,计算细胞迁徙距离;光照后1 h行H2DCFDA染色并分别以荧光法及流式细胞术测定活性氧生成(ROS);光照24 h后行MTT实验、Hoechst33342/PI双重染色、蛋白印迹法(Western blotting)评价细胞增殖活力、细胞核形态及eNOS、p-c-Jun、EGFR表达。结果:①9-HPbD-PDT显著抑制HN-3细胞增殖,9-HPbD单独孵育(未进行激光照射)与单纯激光照射均未显示对HN-3细胞的生长抑制。②PDT后HN-3细胞活性氧产生明显增加,细胞核浓缩、碎裂,eNOS、p-c-Jun表达上调。③9-HPbD-PDT显著抑制HN-3细胞迁徙能力,呈光敏剂剂量相关性。PDT后HN-3细胞EGFR表达下调。④以活性氧阻滞剂谷胱甘肽(GSH)、抗坏血酸预孵育HN-3细胞,光动力触发的凋亡诱导、迁徙抑制等被部分阻滞。 结论:①9-HPbD-PDT对HN-3细胞具有光化学毒性,p-c-Jun通路激活及eNOS表达上调、EGFR表达下调可能参与了细胞凋亡与迁徙抑制的诱导。②活性氧生成在9-HPbD-PDT诱导HN-3细胞凋亡与迁徙抑制中发挥重要作用。
  • 加载中
  • [1]

    DOLMANS D E,FUKUMURA D,JAIN R K.Photodynamic therapy for cancer[J].Nat Rev Cancer,2003,3:380-387.

    [2]

    AHN J C.The apoptosis pathway of photodynamic therapy using 9-HpbD-a in AMC-HN3 human head and neck cancer cell line and in vivo[J].Gen Physiol Biophys,2013,32:405-413.

    [3]

    KIM S Y,CHU K C,LEE H R,et al.Establishment and characterization of nine new head and neck cancer cell lines[J].Acta Otolaryngol,1997,117:775-784.

    [4]

    HE P,AHN J C,SHIN J I,et al.Enhanced apoptotic effect of combined modality of 9-hydroxypheophorbide alpha-mediated photodynamic therapy and carboplatin on AMC-HN-3 human head and neck cancer cells[J].Oncol Rep,2009,21:329-334.

    [5]

    BUYTAERT E,DEWAELE M,AGOSTINIS P.Molecular effectors of multiple cell death pathways initiated by photodynamic therapy[J].Biochim Biophys Acta,2007,1776:86-107.

    [6]

    OLEINICK N L,EVANS H H.The photobiology of photodynamic therapy:cellular targets and mechanisms[J].Radiat Res,1998,150(5Suppl):S146-S156.

    [7]

    HE P,AHN J C,SHIN J I,et al.Photoactivation of 9-hydroxypheophorbide alpha triggers apoptosis through the reactive oxygen species-mediated mitochondrial pathway and endoplasmic reticulum stress in AMC-HN-3laryngeal cancer cells[J].Int J Oncol,2010,36:801-808.

    [8]

    STANDER X X,STANDER B A,JOUBERT A M.Synergistic anticancer potential of dichloroacetate and estradiol analogue exerting their effect via ROS-JNKBcl-2-mediated signalling pathways[J].Cell Physiol Biochem,2015,35:1499-1526.

    [9]

    FUKUMURA D,KASHIWAGI S,JAIN R K.The role of nitric oxide in tumour progression[J].Nat Rev Cancer,2006,6:521-534.

    [10]

    SHAKED Y,VOEST E E.Bone marrow derived cells in tumor angiogenesis and growth:are they the good,the bad or the evil[J]?Biochim Biophys Acta,2009,1796:1-4.

    [11]

    LI C S,NEU M B,SHAW L C,et al.EPCs and pathological angiogenesis:when good cells go bad[J].Microvasc Res,2010,79:207-216.

    [12]

    梅开,蔡晓虹,杜磊,等.内皮型一氧化氮合酶来源的NO调节肿瘤血管的生成[J].癌症,2010,29(1):32-37.

    [13]

    KALYANKRISHNA S,GRANDIS J R.Epidermal growth factor receptor biology in head and neck cancer[J].J Clin Oncol,2006,24:2666-2672.

    [14]

    YANMAZ M T,DEMIR G,ERDAMAR S,et al.Epidermal growth factor receptor in CRC patients in the era of the RAS[J].Hepatogastroenterology,2015,62:40-44.

    [15]

    MARTINEZ-USEROS J,GARCIA-FONCILLAS J.The challenge of blocking a wider family members of EGFR against head and neck squamous cell carcinomas[J].Oral Oncol,2015,51:423-430.

  • 加载中
计量
  • 文章访问数:  138
  • PDF下载数:  132
  • 施引文献:  0
出版历程
收稿日期:  2015-03-25

目录